| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |